Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner

作者: Jin Young Lee , Byung Ho Lee , Nam Doo Kim , Joo Young Lee

DOI: 10.1016/J.JEP.2015.06.028

关键词:

摘要: Abstract Ethnopharmacological relevance Tripterygium wilfordii (lei gong teng; Thunder of God Vine), which belongs to the Celastraceae family, has long been used in traditional Chinese medicine treat inflammation and rheumatoid arthritis. Celastrol is a bioactive compound isolated from T. wilfordii. Aim study We investigated whether celastrol suppressed binding lipopolysaccharides (LPS) myeloid differentiation factor 2 (MD2), thereby downregulating Toll-like receptor4 (TLR4) activation mouse primary macrophages. Materials methods Cytokine expression was determined by polymerase chain reaction analysis enzyme-linked immunosorbent assay bone marrow-derived macrophages (BMDMs). The kinase activity tank-binding 1 (TBK1) examined luciferase reporter an vitro assay. LPS MD2 confocal microscopy analysis. Results reduced LPS-induced inflammatory cytokines, such as tumor necrosis (TNF)-α, interleukin (IL)-6, IL-12, IL-1β, at both mRNA protein levels BMDMs. MD2, shown assay, whereas it did not inhibit TBK1. In addition, co-localization with BMDMs blocked celastrol. inhibitory effects on were reversed thiol donors (N-acetyl- L -cysteine dithiothreitol), suggesting that reactivity contributes its TLR4 Conclusion Our results demonstrate suppresses through inhibition TLR4/MD2 complex. These provide novel mechanism action anti-inflammatory .

参考文章(22)
So Young Kim, Jung Eun Koo, Yun Jee Seo, Nisha Tyagi, Eunshil Jeong, Jaeyoung Choi, Kyung-Min Lim, Zee-Yong Park, Joo Young Lee, Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. British Journal of Pharmacology. ,vol. 168, pp. 1933- 1945 ,(2013) , 10.1111/BPH.12091
Sun Myung Joung, Zee-Yong Park, Shilpa Rani, Osamu Takeuchi, Shizuo Akira, Joo Young Lee, Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1 Journal of Immunology. ,vol. 186, pp. 499- 507 ,(2011) , 10.4049/JIMMUNOL.0903534
Eunshil Jeong, Jung Eun Koo, Sang Hyeon Yeon, Mi-Kyoung Kwak, Daniel H. Hwang, Joo Young Lee, PPARδ deficiency disrupts hypoxia‐mediated tumorigenic potential of colon cancer cells Molecular Carcinogenesis. ,vol. 53, pp. 926- 937 ,(2014) , 10.1002/MC.22144
Anthony C. Allison, Ramon Cacabelos, Valter R.M. Lombardi, Xoan A. Álvarez, Carmen Vigo, Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 25, pp. 1341- 1357 ,(2001) , 10.1016/S0278-5846(01)00192-0
Guillaume F. Pinna, Marc Fiorucci, Jean-Marie Reimund, Nathalie Taquet, Yves Arondel, Christian D. Muller, Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies Biochemical and Biophysical Research Communications. ,vol. 322, pp. 778- 786 ,(2004) , 10.1016/J.BBRC.2004.07.186
Jun Kyung Lee, So Young Kim, Yoon Sun Kim, Won-Ha Lee, Daniel H Hwang, Joo Young Lee, None, Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin Biochemical Pharmacology. ,vol. 77, pp. 1391- 1400 ,(2009) , 10.1016/J.BCP.2009.01.009
Antero Salminen, Marko Lehtonen, Tuomas Paimela, Kai Kaarniranta, Celastrol: Molecular targets of Thunder God Vine Biochemical and Biophysical Research Communications. ,vol. 394, pp. 439- 442 ,(2010) , 10.1016/J.BBRC.2010.03.050
Jung Eun Koo, Zee-Yong Park, Nam Doo Kim, Joo Young Lee, Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2 Biochemical and Biophysical Research Communications. ,vol. 434, pp. 600- 605 ,(2013) , 10.1016/J.BBRC.2013.03.123
In-geun Ryoo, Dong-ha Shin, Kyung-Shin Kang, Mi-Kyoung Kwak, Involvement of Nrf2-GSH signaling in TGFβ1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells Archives of Pharmacal Research. ,vol. 38, pp. 272- 281 ,(2015) , 10.1007/S12272-014-0380-Y